NASDAQ
PRTA
Last Price
US $8.64
KEY FIGURES
MKT CAP
$452.3M
EPS
TTM
$-2.81
PEG
TTM
N/M
P/E
TTM
N/M
P/S
TTM
8.01x
YIELD
0.00%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Prothena Corporation plc cash flow to debt ratio of -1.18K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
Prothena Corporation plc's free cash flow has decreased 8.89% from $-150.35M last year to $-163.72M, signaling decreasing performance
Financial stability - Healthy debt to equity ratio.
Prothena Corporation plc's debt to equity ratio is 0.02, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
Prothena Corporation plc's debt has decreased relative to shareholder equity from 0.02 last year to 0.02 today, signaling strengthened financials
Financial risk - Net debt/EBITDA.
Prothena Corporation plc has negative EBITDA, making leverage ratio unreliable
Financial stability - ICR.
Prothena Corporation plc earns at least as much interest as it pays. Interest obligations are fully covered.
Financial risk - Profit margin growth.
Prothena Corporation plc's profit margin has decreased (188.32%) in the last year from -90.49% to -260.92%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
Prothena Corporation plc's short-term assets of $315.19M exceed its short-term liabilities of $40.84M
Decreasing performance - ROA.
Prothena Corporation plc's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Prothena Corporation plc's return on equity of -49.88%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Prothena Corporation plc's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Prothena Corporation plc had positive net income in only 1.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
Prothena Corporation plc has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Prothena Corporation plc has negative free cash flow, indicating cash burn
Decreasing performance - Healthy earnings growth.
Prothena Corporation plc's yearly earnings has decreased 99.57% since last year from $-122.31M to $-244.09M, signaling decreasing performance
Decreasing performance - Healthy revenue growth.
Prothena Corporation plc's yearly revenue has decreased -92.83% since last year from $135.16M to $9.68M, signaling decreasing performance
Decreasing performance - ROIC.
ROIC -39.43% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Decreasing performance - 3-year revenue CAGR.
Prothena Corporation plc's 3-year revenue CAGR of -43.57% is negative, indicating declining revenue over the past 3 years
Increasing performance - Revenue consistency.
Prothena Corporation plc had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
Prothena Corporation plc had positive ROE in only 1.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Prothena Corporation plc has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Prothena Corporation plc has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Prothena Corporation plc is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Prothena Corporation plc has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Prothena Corporation plc has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
Prothena Corporation plc has a price-to-book ratio of 1.48x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Overvalued - P/S ratio.
Prothena Corporation plc has a price-to-sales ratio of 8.01x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
-49.88%
Return on equity
ROIC: -39.43%
Valuation History
-3.3X
Price to Earnings
EV/EBITDA: -2.2X
Cash flow
Profit margin
62.56%
(FY vs FY)
EBITDA Y/Y
-10.82%
(FY vs FY)
Cash flow Y/Y
-13.22%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $8.64
—
Default assumptions
EBITDA Multiple
Fair Value
Market $8.64
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.